COVID-19 Outbreak-Global Transfection Technologies Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Transfection commonly refers to the introduction of nucleic acids into eukaryotic cells, or more specifically, into animal cells. Classically, the term transfection was used to denote the uptake of viral nucleic acid from a prokaryote‑infecting virus or bacteriophage, resulting in an infection and the production of mature virus particles. However, the term has acquired its present meaning to include any artificial introduction of foreign nucleic acid into a cell.
The Transfection Technologies market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Transfection Technologies industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Transfection Technologies market can be split based on product types, major applications, and important countries as follows:

Key players in the global Transfection Technologies market covered in Chapter 12:
Agilent Technologies
Clontech
Chemicell
Inovio Pharmaceuticals
Oz Biosciences
Affymetrix
Promega Corporation
MaxCyte
Miltenyi Biotec
Polyplus Transfection
Bio-Rad
IBA GmbH
Thermo Fisher Scientific
Lonza
GE Healthcare Life Sciences
CytoPulse
Altogen Biosystems
Merck KGaA
Boca Scientific
Deliverics

In Chapter 4 and 14.1, on the basis of types, the Transfection Technologies market from 2015 to 2025 is primarily split into:
Lipofection
Electroporation
Nucleofection
Others

In Chapter 5 and 14.2, on the basis of applications, the Transfection Technologies market from 2015 to 2025 covers:
Research Centers & Academic/Government Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025